BridgeMD
New treatment option for Endometriosis
Official title Impact of Dietary Guidance and Probiotics in the Treatment of Endometriosis and Irritable Bowel Syndrome in Women
ClinicalTrials.gov ID: NCT07149519
What this study is testing
- What it's testing
- Patients with endometriosis are 2 to 3 times more likely to develop Irritable Bowel Syndrome (IBS) than women without the condition. IBS presents symptoms similar to those of intestinal and deep EDT, leading to diagnostic errors and delays in identifying such comorbidities.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 50, women only
You may be able to join if
- Women between 18 and 50 years of age who wish to participate in the clinical trial;
- Willingness to voluntarily participate in the study and accept randomization to any of the three treatment arms;
- Participating exclusively in this clinical trial during the study period;
- Signing the Informed Consent Form (ICF) approved by the Research Ethics Committee (CEP) and CONEP
You likely can't join if
- Chronic, severe, or uncompensated clinical conditions, such as: malnutrition (BMI \<18); insulin-dependent diabetes (types 1 or 2); uncontrolled...
- Clinical conditions of the gastrointestinal tract that cause IBS-like symptoms, such as: inflammatory bowel disease (Chron's disease, ulcerative...
- Endometriosis requiring surgical treatment during the study period;
- Severe eating disorders, such as: bulimia, anorexia nervosa, and binge-eating disorder;
- Chronic use of any medication with potential interaction with probiotics, the intestinal microbiota, or the natural progression of the disease in the...
- Patients who already consume healthy foods or are on a restrictive diet more than four days a week, which may affect the evaluation results;
See the full eligibility criteria
- Women between 18 and 50 years of age who wish to participate in the clinical trial;
- Willingness to voluntarily participate in the study and accept randomization to any of the three treatment arms;
- Participating exclusively in this clinical trial during the study period;
- Signing the Informed Consent Form (ICF) approved by the Research Ethics Committee (CEP) and CONEP
- Chronic, severe, or uncompensated clinical conditions, such as: malnutrition (BMI \<18); insulin-dependent diabetes (types 1 or 2); uncontrolled hypertension; lung disease such as asthma or other chronic obstructive...
- Clinical conditions of the gastrointestinal tract that cause IBS-like symptoms, such as: inflammatory bowel disease (Chron's disease, ulcerative colitis), microscopic colitis, celiac disease, and lactose intolerance;
- Endometriosis requiring surgical treatment during the study period;
- Severe eating disorders, such as: bulimia, anorexia nervosa, and binge-eating disorder;
- Chronic use of any medication with potential interaction with probiotics, the intestinal microbiota, or the natural progression of the disease in the last 6 months (such as probiotics, antibiotics, antifungals...
- Patients who already consume healthy foods or are on a restrictive diet more than four days a week, which may affect the evaluation results;
- Patients whose stool protopastological examination is altered;
- Inability to use oral medication;
- Pregnancy or lactation;
- History of alcohol or drug dependence;
- Smoking in the last three years;
- Inability to cooperate with investigators due to cognitive impairment or mental state.
The study team makes the final eligibility decision.
Where it's taking place
- Catanduva, São Paulo, Brazil
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 15 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Catanduva, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.